Investor Overview

Corporate Profile

Investor Highlights

Corporate Profile

Read Now
Corporate Profile

Investor Presentation

Read Now


Our Pipeline

Learn More
  • Price
  • Change

  • Copyright West LLC.
    Minimum 15 minutes delayed.
Recent Releases

Recent Releases

January 13, 2020

EUSA Pharma and BeiGene Announce Exclusive Development and Commercialization Agreement for SYLVANT® and QARZIBA®▼ in Greater China

January 8, 2020

BeiGene to Present at the 38th Annual J.P. Morgan Healthcare Conference

January 3, 2020

Leap Therapeutics and BeiGene Announce Exclusive Option and License Agreement for DKN-01 and Leap Announces $27 Million Equity Financing

Key Metrics

Key Metrics

  • 3,300+


  • 1,000+

    Clinical team

  • 4


This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.